Your Article Summary
See Latest ArticlesAnti-TNFalpha blockers, autoantibodies and autoimmune diseases
Joint, Bone, Spine, 06/25/09
Caramaschi P et al. - While the development of antinuclear and, less frequently, of anti-DNA antibodies is a common finding, the onset of autoimmune diseases during anti-TNFalpha blocker treatment is a rare event, which needs to be promptly recognized in order to plan the appropriate management. Moreover the specific autoantibodies associated with rheumatoid arthritis are considered before and after biotherapy.
Related Articles
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies
European Journal of Endocrinology, 11/05/09
Relevance Score: 69%
Cross-regulation of Signaling Pathways by Interferon-[gamma]: Implications for Immune Responses and Autoimmune Diseases
Immunity, 10/28/09
Relevance Score: 69%
iTRAQ-based proteomic identification of leucine rich alpha 2 glycoprotein (LRG) as a novel inflammatory biomarker in autoimmune diseases
Annals of Rheumatic Diseases, 11/09/09
Relevance Score: 68%
Familial clustering, genetic roots and insights into the pathogenesis of autoimmune diseases
Zeitschrift für Rheumatologie, 10/29/09
Relevance Score: 68%
Autoimmune pancreatitis: A mimic of pancreatic cancer
Cleveland Clinic Journal of Medicine, 10/16/09
Relevance Score: 68%
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Brain magnetic resonance imaging findings in patients with systemic sclerosis
International Journal of Rheumatic Diseases, 12/15/09
Gastrointestinal manifestation of systemic sclerosis—thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign
Rheumatology, 12/15/09
Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease Damage: a proof-of-concept study
Rheumatology, 12/15/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
First-line DMARD choice in early rheumatoid arthritis - Do prognostic factors play a role?
Rheumatology, 12/15/09
Use of oral bisphosphonates and risk of venous thromboembolism: A population-based case-control study
Osteoporosis International, 12/15/09
Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-&alpha blocker therapy
Rheumatology, 12/15/09